Evaluating Biomaterial- and Microfluidic-Based 3D Tumor Models.

Area of Science:

• Oncology
• Biomedical Engineering
• Regenerative Medicine

Background:

• Cancer poses a significant global health challenge, with increasing morbidity and mortality.
• Traditional 2D cell cultures inadequately represent cancer's complexity and biological mechanisms.
• There is a critical need for advanced models to bridge the gap between laboratory research and clinical applications.

Purpose of the Study:

• To review the current state-of-the-art in 3D tissue-engineering (TE) models for cancer research.
• To assess the potential of scaffold-based TE and microfluidics in improving cancer models.
• To discuss advancements in combining 3D TE and microfluidics, focusing on biomaterials and chip-based models.

Main Methods:

• Review of current literature on 3D tissue-engineering models in cancer research.
• Assessment of scaffold-based TE models and microfluidic systems.
• Discussion of recent advances in biomaterials and chip-based 3D models integrating TE and microfluidics.

Main Results:

• 3D TE models and microfluidics show significant promise in addressing the limitations of 2D cell cultures for cancer research.
• Scaffold-based TE models offer improved in vitro environments for studying cancer biology.
• Integrated 3D TE and microfluidic systems, particularly chip-based models utilizing advanced biomaterials, represent the cutting edge.

Conclusions:

• 3D tissue engineering and microfluidics are crucial for developing more biologically relevant cancer models.
• These advanced models have the potential to accelerate the translation of research findings to clinical applications.
• Continued innovation in biomaterials and microfluidic chip design will further enhance their utility in oncology.